Morin hydrate
SIGMA/M4008 - powder
Synonym: 2′,3,4′,5,7-Pentahydroxyflavone
CAS Number: 654055-01-3
Empirical Formula (Hill Notation): C15H10O7 · xH2O
Molecular Weight: 302.24 (anhydrous basis)
EC Number: 207-542-9
MDL Number: MFCD00217054
Linear Formula: C15H10O7 · xH2O
Product Type: Chemical
| color | yellow |
| form | powder |
| InChI | 1S/C15H10O7.H2O/c16-6-1-2 |
| InChI key | MYUBTSPIIFYCIU-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | O.Oc1ccc(c(O)c1)C2=C(O)C( |
| solubility | methanol: 50 mg/mL |
| Application: | Morin hydrate has been used: • to investigate its antitumor functionality using cell viability and apoptosis assay in human cancer cell lines. • as a fluorescence stain to detect aluminum in motor neurons and lumbar cord. • to study its protective effect on neuronal hearing loss and on neural stem cells (NSCs) proliferation and differentiation |
| Biochem/physiol Actions: | Morin hydrate is a flavonoid with antioxidant properties. It has been shown to protect cells against oxygen radical damage. Morin not only scavenges oxyradicals, but also moderately inhibits xanthine oxidase, a free-radical generating enzyme. At concentrations of 75-100 micromolar, morin inhibits oxidation of low density lipoprotein (LDL) by free radicals or Cu2+. Morin has been reported to inhibit rat brain phosphatidylinositolph |
| Packaging: | 2, 5, 10 g in poly bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| UNSPSC | 12171500 |


